Joseph Stringer
Stock Analyst at Needham
(4.59)
# 228
Out of 5,124 analysts
324
Total ratings
49.83%
Success rate
39.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joseph Stringer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $120 → $145 | $107.04 | +35.46% | 28 | Dec 11, 2025 | |
| CDTX Cidara Therapeutics | Downgrades: Hold | n/a | $220.89 | - | 17 | Nov 14, 2025 | |
| GILD Gilead Sciences | Maintains: Buy | $133 → $140 | $122.74 | +14.06% | 9 | Nov 13, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $78 → $90 | $79.11 | +13.77% | 25 | Oct 30, 2025 | |
| RNA Avidity Biosciences | Downgrades: Hold | $65 | $72.13 | -9.88% | 19 | Oct 27, 2025 | |
| MRNA Moderna | Reiterates: Hold | n/a | $29.49 | - | 9 | Oct 20, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $22 → $35 | $31.74 | +10.27% | 24 | Oct 10, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $377 → $478 | $397.65 | +20.21% | 23 | Jul 31, 2025 | |
| PHAT Phathom Pharmaceuticals | Maintains: Buy | $28 | $16.59 | +68.78% | 52 | Jun 6, 2025 | |
| VIR Vir Biotechnology | Reiterates: Buy | $14 | $6.03 | +132.17% | 18 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $11 | $5.02 | +119.12% | 19 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $29 | $25.12 | +15.45% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $453.36 | - | 6 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $46.14 | +95.06% | 17 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.15 | - | 13 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 | $1.22 | +719.67% | 17 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $37 | $26.71 | +38.52% | 6 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $18.71 | -3.79% | 2 | Aug 24, 2021 |
Rhythm Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $120 → $145
Current: $107.04
Upside: +35.46%
Cidara Therapeutics
Nov 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $220.89
Upside: -
Gilead Sciences
Nov 13, 2025
Maintains: Buy
Price Target: $133 → $140
Current: $122.74
Upside: +14.06%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $78 → $90
Current: $79.11
Upside: +13.77%
Avidity Biosciences
Oct 27, 2025
Downgrades: Hold
Price Target: $65
Current: $72.13
Upside: -9.88%
Moderna
Oct 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $29.49
Upside: -
Stoke Therapeutics
Oct 10, 2025
Maintains: Buy
Price Target: $22 → $35
Current: $31.74
Upside: +10.27%
Alnylam Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $377 → $478
Current: $397.65
Upside: +20.21%
Phathom Pharmaceuticals
Jun 6, 2025
Maintains: Buy
Price Target: $28
Current: $16.59
Upside: +68.78%
Vir Biotechnology
May 22, 2025
Reiterates: Buy
Price Target: $14
Current: $6.03
Upside: +132.17%
May 13, 2025
Maintains: Buy
Price Target: $16 → $11
Current: $5.02
Upside: +119.12%
May 7, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $25.12
Upside: +15.45%
May 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $453.36
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $90
Current: $46.14
Upside: +95.06%
Mar 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.15
Upside: -
Mar 4, 2025
Downgrades: Hold
Price Target: $10
Current: $1.22
Upside: +719.67%
Jan 24, 2024
Upgrades: Buy
Price Target: $37
Current: $26.71
Upside: +38.52%
Aug 24, 2021
Maintains: Buy
Price Target: $32 → $18
Current: $18.71
Upside: -3.79%